GENELUX Corp
GNLX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001231457
In the last 90 days, GENELUX Corp insiders filed 0 open-market purchases and 6 sales; 72 institutions reported holding it in 13F filings for Q2 2026, worth $29.5M in total; no superinvestor holds it.
Q3 2023 vs. Q2 2023
How the institutions holding GENELUX Corp changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 35 | 56 | +21 |
| Shares | 497.5K | 4.24M | +3.75M (+752.9%) |
| Value | $16.3M | $103.9M | +$87.6M (+538.4%) |
New holders (25)
Institutions that held GENELUX Corp at the end of Q3 2023 but not at the end of Q2 2023.
Sold out (4)
Institutions that held GENELUX Corp at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Hohimer Wealth Management, LLC | 24,640 | $806.2K |
| Mark Stevens | 9,328 | $305.2K |
| Jane Street Group, LLC | 7,226 | $236.4K |
| Atlas Private Wealth Advisors | 6,120 | $200.2K |